Equity and diversity in academic medicine: A perspective from the JCI editors

Linda M.S. Resar; Elizabeth M. Jaffee; Mary Armanios; Sarah Jackson; Nilofer S. Azad; Maureen Horton; Mariana J. Kaplan; Marikki Laiho; Marcela V. Maus; Charlotte J. Sumner; Sarah Wheelan; Marsha Wills-Karp

doi:10.1172/JCI130902

Equity and diversity in academic medicine: A perspective from the JCI editors

Linda M.S. Resar, Elizabeth M. Jaffee, Mary Armanios, Sarah Jackson, Nilofer S. Azad, Maureen Horton, Mariana J. Kaplan, Marikki Laiho, Marcela V. Maus, Charlotte J. Sumner, Sarah Wheelan, Marsha Wills-Karp

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Journal	Journal of Clinical Investigation
Volume	129
Issue number	10
DOIs	https://doi.org/10.1172/JCI130902
State	Published - Oct 1 2019

ASJC Scopus subject areas

General Medicine

Access to Document

10.1172/JCI130902

Cite this

@article{b8bc4904d867477083670b438355d239,

title = "Equity and diversity in academic medicine: A perspective from the JCI editors",

author = "Resar, {Linda M.S.} and Jaffee, {Elizabeth M.} and Mary Armanios and Sarah Jackson and Azad, {Nilofer S.} and Maureen Horton and Kaplan, {Mariana J.} and Marikki Laiho and Maus, {Marcela V.} and Sumner, {Charlotte J.} and Sarah Wheelan and Marsha Wills-Karp",

note = "Funding Information: Authorship note: MJK contributed to this article in her personal capacity. The views expressed are her own and do not necessarily represent the views of the National Institutes of Health or the United States Government. Conflict of interest: EMJ receives research funding from Bristol-Myers Squibb and Aduro Biotech, is on the advisory board for Genocea Biosciences, and has the potential to receive royalties from Aduro Biotech. NSA receives research funding from Bristol-Myers Squibb, Merck, Celgene, Sydax, Astex, Intensity Therapeutics, Incyte, Debio, and Tanabe. MH is an advisor for Vicore and has received research funding from Roche. MJK receives research funding from Med-Immune. ML receives research funding from Bluefield Innovations. MVM has received funding from Agenus, Crispr Therapeutics, Kite Pharma, and royalties from Novartis via the University of Pennsylvania. CJS has received funding from Ionis Pharmaceuticals. MWK has received funding from Apellis Pharmaceuticals. Copyright: {\textcopyright} 2019, American Society for Clinical Investigation. Reference information: J Clin Invest. https://doi.org/10.1172/JCI130902.",

year = "2019",

month = oct,

day = "1",

doi = "10.1172/JCI130902",

language = "English (US)",

volume = "129",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "The American Society for Clinical Investigation",

number = "10",

}

TY - JOUR

T1 - Equity and diversity in academic medicine

T2 - A perspective from the JCI editors

AU - Resar, Linda M.S.

AU - Jaffee, Elizabeth M.

AU - Armanios, Mary

AU - Jackson, Sarah

AU - Azad, Nilofer S.

AU - Horton, Maureen

AU - Kaplan, Mariana J.

AU - Laiho, Marikki

AU - Maus, Marcela V.

AU - Sumner, Charlotte J.

AU - Wheelan, Sarah

AU - Wills-Karp, Marsha

N1 - Funding Information: Authorship note: MJK contributed to this article in her personal capacity. The views expressed are her own and do not necessarily represent the views of the National Institutes of Health or the United States Government. Conflict of interest: EMJ receives research funding from Bristol-Myers Squibb and Aduro Biotech, is on the advisory board for Genocea Biosciences, and has the potential to receive royalties from Aduro Biotech. NSA receives research funding from Bristol-Myers Squibb, Merck, Celgene, Sydax, Astex, Intensity Therapeutics, Incyte, Debio, and Tanabe. MH is an advisor for Vicore and has received research funding from Roche. MJK receives research funding from Med-Immune. ML receives research funding from Bluefield Innovations. MVM has received funding from Agenus, Crispr Therapeutics, Kite Pharma, and royalties from Novartis via the University of Pennsylvania. CJS has received funding from Ionis Pharmaceuticals. MWK has received funding from Apellis Pharmaceuticals. Copyright: © 2019, American Society for Clinical Investigation. Reference information: J Clin Invest. https://doi.org/10.1172/JCI130902.

PY - 2019/10/1

Y1 - 2019/10/1

UR - http://www.scopus.com/inward/record.url?scp=85072791999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072791999&partnerID=8YFLogxK

U2 - 10.1172/JCI130902

DO - 10.1172/JCI130902

M3 - Comment/debate

C2 - 31524636

AN - SCOPUS:85072791999

SN - 0021-9738

VL - 129

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 10

ER -

Equity and diversity in academic medicine: A perspective from the JCI editors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this